Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
13.97
-0.15 (-1.10%)
Real-time:   12:01PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.84 - 14.24
52 week 5.27 - 14.69
Open 14.17
Vol / Avg. 58,913.00/542,652.00
Mkt cap 608.90M
P/E     -
Div/yield     -
EPS -0.24
Shares     -
Beta     -
Inst. own     -
Aug 2, 2013
Q2 2013 NOVADAQ TECHNOLOGIES INC Earnings Release Add to calendar
May 31, 2013
Novadaq to Ring NASDAQ Stock Market Opening Bell - 9:15AM EDT - Add to calendar
May 30, 2013
NOVADAQ TECHNOLOGIES INC at Deutsche Bank dbAccess Health Care Conference - 11:20AM EDT - Add to calendar
May 29, 2013
NOVADAQ TECHNOLOGIES INC at Craig-Hallum Capital Group Institutional Investor Conference - 1:45PM EDT - Add to calendar
May 22, 2013
NOVADAQ TECHNOLOGIES INC Annual Shareholder Meeting
May 15, 2013
NOVADAQ TECHNOLOGIES INC at Bank of America Merrill Lynch Health Care Conference
May 1, 2013
Q1 2013 NOVADAQ TECHNOLOGIES INC Earnings Release
Apr 29, 2013
Q1 2013 NOVADAQ TECHNOLOGIES INC Earnings Conference Call
Feb 27, 2013
NOVADAQ TECHNOLOGIES INC at Citi Global Healthcare Conference
Feb 26, 2013
NOVADAQ TECHNOLOGIES INC at RBC Capital Markets' Healthcare Conference
More events from DailyFinance »    

Address

Suite 306 2585 Skymark Avenue
MISSISSAUGA, ON L4W 4L5
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. It manufactures SPY systems, FIREFLY hardware components, and PINPOINT Systems at its manufacturing facility located in Richmond British Columbia. The Company�s SPY imaging core technology platform provides clinically anatomic and physiologic images during a variety of complex surgical procedures. The SPY technology platform allows for the development of specific devices based on the needs of the surgeon and the specific application. Effective February 1, 2011, it acquired Laser System Business for Transmyocardial Revascularization.

Officers and directors

Arun Menawat President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Stephen Purcell Chief Financial Officer
Bio & Compensation  - Reuters
Rick Mangat Ph.D. Senior Vice President, General Manager
Bio & Compensation  - Reuters
Mary Kay Baggs Senior Vice President - Marketing and Business Development
Bio & Compensation  - Reuters
Roger Deck Vice President - Operations
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Age: 82
Bio & Compensation  - Reuters
G. Steven Burrill Independent Director
Age: 67
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Age: 44
Bio & Compensation  - Reuters
Harold O. Koch Jr. Independent Director
Bio & Compensation  - Reuters
Julia G. Levy Ph.D. Independent Director
Bio & Compensation  - Reuters